Class 3 semaphorins and their receptors in physiological and pathological angiogenesis

被引：27
作者：
Staton, Carolyn A. [1 ]
机构：
[1] Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Surg Oncol, Microcirculat Res Grp, Sheffield S10 2RX, S Yorkshire, England
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2011年 / 39卷
关键词：
angiogenesis; class; 3; semaphorin; neuropilin; plexin; vascular endothelial growth factor (VEGF); ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; HORMONAL-REGULATION; PLEXIN D1; NEUROPILIN-1; CELLS; VEGF; LUNG; CANCER; GENES;
D O I：
10.1042/BST20110654
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Class 3 semaphorins (Sema3) are a family of secreted proteins that were originally identified as axon guidance factors mediating their signal transduction by forming complexes with neuropilins and plexins. However, the wide expression pattern of Sema3 suggested additional functions other than those associated with the nervous system, and indeed many studies have now indicated that Sema3 proteins and their receptors play a role in angiogenesis. The present review specifically focuses on recent evidence for this role in both physiological and pathological angiogenesis.
引用
收藏
页码：1565 / 1570
页数：6
相关论文
共 69 条
  • [11] Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
    Casazza, Andrea
    Finisguerra, Veronica
    Capparuccia, Lorena
    Camperi, Andrea
    Swiercz, Jakub M.
    Rizzolio, Sabrina
    Rolny, Charlotte
    Christensen, Claus
    Bertotti, Andrea
    Sarotto, Ivana
    Risio, Mauro
    Trusolino, Livio
    Weitz, Jurgen
    Schneider, Martin
    Mazzone, Massimilano
    Comoglio, Paolo M.
    Tamagnone, Luca
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (08) : 2684 - 2698
  • [12] Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect
    Castro-Rivera, E
    Ran, S
    Thorpe, P
    Minna, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) : 11432 - 11437
  • [13] The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis
    Catalano, Alfonso
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (10) : 6373 - 6383
  • [14] Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections
    Cheng, HJ
    Bagri, A
    Yaron, A
    Stein, E
    Pleasure, SJ
    Tessier-Lavigne, M
    [J]. NEURON, 2001, 32 (02) : 249 - 263
  • [15] Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Mullerian Tissues
    Drenberg, Christina D.
    Livingston, Sandra
    Chen, Ren
    Kruk, Patricia A.
    Nicosia, Santo V.
    [J]. OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2009, 2009
  • [16] PlexinD1 and semaphorin signaling are required in endothelial cells for cadiovascular development
    Gitler, AD
    Lu, MM
    Epstein, JA
    [J]. DEVELOPMENTAL CELL, 2004, 7 (01) : 107 - 116
  • [17] Expression of Semaphorin-3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation
    Gomez, C
    Burt-Pichat, B
    Mallein-Gerin, F
    Merle, B
    Delmas, PD
    Skerry, TM
    Vico, L
    Malaval, L
    Chenu, C
    [J]. DEVELOPMENTAL DYNAMICS, 2005, 234 (02) : 393 - 403
  • [18] Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development
    Gu, CH
    Rodriguez, ER
    Reimert, DV
    Shu, TZ
    Fritzsch, B
    Richards, LJ
    Kolodkin, AL
    Ginty, DD
    [J]. DEVELOPMENTAL CELL, 2003, 5 (01) : 45 - 57
  • [19] Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins
    Gu, CH
    Yoshida, Y
    Livet, J
    Reimert, DV
    Mann, F
    Merte, J
    Henderson, CE
    Jessell, TM
    Kolodkin, AL
    Ginty, DD
    [J]. SCIENCE, 2005, 307 (5707) : 265 - 268
  • [20] The neuropilins and their role in tumorigenesis and tumor progression
    Guttmann-Raviv, N
    Kessler, O
    Shraga-Heled, N
    Lange, T
    Herzog, Y
    Neufeld, G
    [J]. CANCER LETTERS, 2006, 231 (01) : 1 - 11
1234567